79 related articles for article (PubMed ID: 16461355)
1. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
[TBL] [Abstract][Full Text] [Related]
2. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
[TBL] [Abstract][Full Text] [Related]
4. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity.
Patel S; Carrier EJ; Ho WS; Rademacher DJ; Cunningham S; Reddy DS; Falck JR; Cravatt BF; Hillard CJ
J Lipid Res; 2005 Feb; 46(2):342-9. PubMed ID: 15576840
[TBL] [Abstract][Full Text] [Related]
5. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
6. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
Boger DL; Sato H; Lerner AE; Hedrick MP; Fecik RA; Miyauchi H; Wilkie GD; Austin BJ; Patricelli MP; Cravatt BF
Proc Natl Acad Sci U S A; 2000 May; 97(10):5044-9. PubMed ID: 10805767
[TBL] [Abstract][Full Text] [Related]
7. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors.
Kovacs D; Flori E; Bastonini E; Mosca S; Migliano E; Cota C; Zaccarini M; Briganti S; Cardinali G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139209
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Fatty Acid Amide Hydrolase (FAAH) in Hirudo verbana.
Kabeiseman E; Paulsen RT; Burrell BD
Res Sq; 2024 Apr; ():. PubMed ID: 38699363
[TBL] [Abstract][Full Text] [Related]
9. FAAH inhibition ameliorates breast cancer in a murine model.
Tripathy M; Bui A; Henderson J; Sun J; Woods CR; Somani S; Doan T; Louis Sam Titus ASC; Mohan C
Oncotarget; 2023 Oct; 14():910-918. PubMed ID: 37921652
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.
Keith JM; Jones WM; Tichenor M; Liu J; Seierstad M; Palmer JA; Webb M; Karbarz M; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
ACS Med Chem Lett; 2015 Dec; 6(12):1204-8. PubMed ID: 26713105
[TBL] [Abstract][Full Text] [Related]
11. Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls.
Spohrs J; Kühnle V; Mikusky D; Sanhüter N; Macchia A; Nickel S; Abler B
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139281
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Endocannabinoid System for Neuroprotection: A
Zhuang J; Yang DP; Tian X; Nikas SP; Sharma R; Guo JJ; Makriyannis A
J Pharm Pharmacol (Los Angel); 2013; 1(1):. PubMed ID: 24533425
[TBL] [Abstract][Full Text] [Related]
13. Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.
Justinova Z; Panlilio LV; Moreno-Sanz G; Redhi GH; Auber A; Secci ME; Mascia P; Bandiera T; Armirotti A; Bertorelli R; Chefer SI; Barnes C; Yasar S; Piomelli D; Goldberg SR
Neuropsychopharmacology; 2015 Aug; 40(9):2185-97. PubMed ID: 25754762
[TBL] [Abstract][Full Text] [Related]
14. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
15. AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.
Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Góralczyk A; Łuszczki JJ
Pharmacol Rep; 2024 Feb; 76(1):154-170. PubMed ID: 38019413
[TBL] [Abstract][Full Text] [Related]
16. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.
Scheyer A; Yasmin F; Naskar S; Patel S
Neuropsychopharmacology; 2023 Jan; 48(1):37-53. PubMed ID: 36100658
[TBL] [Abstract][Full Text] [Related]
18. Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.
Gagestein B; Stevens AF; Fazio D; Florea BI; van der Wel T; Bakker AT; Fezza F; Dulk HD; Overkleeft HS; Maccarrone M; van der Stelt M
ACS Chem Biol; 2022 May; 17(5):1174-1183. PubMed ID: 35482948
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of endocannabinoid transport in the brain.
Kaczocha M; Haj-Dahmane S
Br J Pharmacol; 2022 Sep; 179(17):4300-4310. PubMed ID: 33786823
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
